Navigation Links
FREE Webinar: Revision of the In Vitro Diagnostic Directive
Date:1/24/2012

RESTON, Va., Jan. 24, 2012 /PRNewswire/ -- BSI's Healthcare Solutions Group is hosting a free webinar on the upcoming changes to the IVD Directive. This free webinar is scheduled for January 26 and is intended to address the growing number of questions about the upcoming changes and how to be prepared.

(Logo: http://photos.prnewswire.com/prnh/20110405/NE77664LOGO)

"We'll do our best in this webinar to help the audience understand the current status and upcoming changes, as well as insight on how to be prepared," said Sue Spencer, BSI's Global Head of IVD, and instructor of global regulatory and compliance training courses. Spencer will discuss the upcoming revisions, and what requirements medical device manufacturers and Notified Bodies can expect to see in the year ahead with the In Vitro Diagnostic Directive. The webinar is FREE to medical device professionals and others interested.

BSI's educational webinar series have educated thousands of medical device professionals around the world. We are committed to guiding the medical device community through the journey of regulations, compliance, and continued education.

Details and registration for upcoming webinar:
Date: Thursday, January 26, 2012
Title: Revision of IVD Directive, Are You Ready?
Time: 11:00 a.m. – 12:00 p.m EST
Registration: https://cc.readytalk.com/r/wyv4wo408ylq
Presenter: Sue Spencer, BSI, Global Head of IVD

Sue Spencer has 26 years of experience in the IVD industry, and has held various positions in R&D, Manufacturing, and Quality Assurance. She joined BSI in 2009 as Head of IVD, where she has developed a full scope Notified Body that can provide a responsive IVD service to clients world-wide.

About BSI
Since 1901, BSI has provided customers with impartial third-party standards-based assurance, compliance, information solutions, and training. BSI is a trusted partner to Industry and Government with over 66,000 organizations, in almost 150 countries, working with over 50 BSI global offices. Our mission is to ensure patient safety while supporting timely access to global medical device technology. We provide thorough, responsive, predictable conformity assessments, evaluations, and certifications that are recognized and accepted worldwide.

BSI is a trusted partner to industry and government with a focus to support their business objectives through the transfer of knowledge of best practices, assurance services to identify and measure performance indicators, training services to aid the building of organizational competency and enable continuous improvement, and the tools to monitor, enhance and report on compliance against the customer's management system objectives.

For additional information, please visit:
www.bsiamerica.com/healthcare

Media Contact for BSI:
Shereen Abuzobaa
VP Marketing & Training
703-464-1931


'/>"/>
SOURCE BSI Group America Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Consumer Health Information - July 28 Webinar: Home Use of Medical Devices
2. FDA Consumer Health Information - Sept. 30 Webinar: Prescription Drug Shortages
3. GSK Statement on FDAs Proposed Label Revisions for Some Asthma Medicines
4. Phase 2b Data Suggest ReVisions Oral Fenretinide (RT-101) Slows Lesion Growth, Preserves Vision and Reduces Incidence of Neovascularization in Geographic Atrophy Patients
5. New Report Indicates VERILAST™ Technology From Smith & Nephew Orthopaedics has Lowest Revision Rate Among all Hip Replacement Materials
6. Zimmer Introduces Comprehensive Range of Trabecular Metal™ Augment Shapes and Cones for Knee Revision Surgery
7. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
8. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
11. MatTeks EpiDerm In Vitro Tissues Headed for Validation in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
Breaking Medicine News(10 mins):